Greensboro, North Carolina
May 10, 2007
Syngenta announced today that Merck & Co. Inc. has granted
Syngenta an exclusive license to use Merck’s manufacturing
technology for the insecticide abamectin in the field of crop
protection, seed treatment, turf and ornamentals. Financial
details of the agreement have not been disclosed.
The use of abamectin based products is expanding rapidly to
replace older insecticides facing regulatory restrictions. “This
license enables Syngenta to significantly expand manufacturing
capacity of abamectin while retaining the high purity associated
with existing Merck manufacturing processes. It underwrites our
investment to support the growth of Agri-Mek®, Avicta®, Avid®
and Proclaim®, all key Syngenta brands based on abamectin,” said
Mike Stepan, insecticide product line head.
Syngenta holds registrations of abamectin in more than 80
countries to control pests at low use rates in fruit, vegetables
and cotton. Key markets are the United States, Europe, Japan and
Korea.
Syngenta is a world-leading agribusiness committed to
sustainable agriculture through innovative research and
technology. The company is a leader in crop protection, and
ranks third in the high-value commercial seeds market. Sales in
2006 were approximately $8.1 billion. Syngenta employs some
19,500 people in over 90 countries. Syngenta is listed on the
Swiss stock exchange (SYNN) and in New York (SYT). Further
information is available at
www.syngenta.com.
Agri-Mek and Proclaim are
Restricted Use Pesticides.
Agri-Mek®, Avicta®, Avid®, Proclaim®, and the Syngenta logo are
trademarks of a Syngenta Group Company. |
|
